SGMO Sangamo Therapeutics
- 0.522
- -0.022-4.01%
- 0.532
- +0.010+1.97%
Sangamo Therapeutics News
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duraibabu Prathyusha
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dubois-Stringfellow Nathalie
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Willoughby Scott B.
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pooler Amy
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Macrae Sandy
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.10%)
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biogen Inc.(8.26%),Biogen MA Inc.(8.26%)
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.9%)
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pooler Amy
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Willoughby Scott B.
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duraibabu Prathyusha
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dubois-Stringfellow Nathalie
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Macrae Sandy
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.53%)
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Willoughby Scott B.
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McClung David Mark
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Macrae Sandy
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fontenot Jason D.
Analysis
Price Target
No Data
